Exploring topics from pharmacokinetics and tubulin targets to schedule dependence and clinical toxicity profiles, this timely work compiles-in a single source-current information on taxanes and their superior activity against small-cell and
non-small-cell lung cancer that will enable researchers to optimize present and future
palliative and curative strategies.Representing international efforts to define the full potential of these chemotherapeutic drugs, Taxanes in
Lung Cancer Therapy furnishes results from ongoing studies involvingnovel mechanisms of action for paclitaxel and docetaxelpaclitaxel exposure duration as well as drug combinations and sequencesphase II trials with paclitaxel in…
